
BDX Stock Forecast & Price Target
BDX Analyst Ratings
Bulls say
Becton Dickinson is a global healthcare company with a focus on organic growth and a strong track record of expected EPS performance. Potential downside scenarios and concerns around sustainability are being addressed, while investments in commercial growth and shareholder returns are expected to support the company's position as a dominant player in the industry.
Bears say
Becton Dickinson is facing multiple headwinds in its four business units, including tariff uncertainty, supply chain issues, and declining organic revenue growth. Despite recent efforts to increase diversity in its workforce, BD may struggle to meet its long-term margin targets and could face challenges in stabilizing its vaccine business. Additionally, with only a limited EPS flow-through from the company's recent guidance raise, it appears that BD's financials may continue to experience underperformance.
This aggregate rating is based on analysts' research of Becton, Dickinson and Co. and is not a guaranteed prediction by Public.com or investment advice.
BDX Analyst Forecast & Price Prediction
Start investing in BDX
Order type
Buy in
Order amount
Est. shares
0 shares